Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728

Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30488-7 · Cited by 2,475

Against which human papillomavirus types shall we vaccinate and screen? the international perspective

Muñóz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjosé, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,095

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

Li, N., Franceschi, S., Howell‐Jones, R., Snijders, P. J. F., & Clifford, G. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25396 · Cited by 1,067

PROPORTION OF DISEASE CAUSED OR PREVENTED BY A GIVEN EXPOSURE, TRAIT OR INTERVENTION1

MIETTINEN, O. S. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121617 · Cited by 1,036

Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer

Guan, P., Howell‐Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., & Clifford, G. M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27485 · Cited by 927

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

SCHIFFMAN, M. H., Clifford, G. M., & Buonaguro, L. (2009) · Infectious Agents and Cancer · doi:10.1186/1750-9378-4-8 · Cited by 463

One virus, one lesion—individual components of CIN lesions contain a specific HPV type

Quint, W. G. V., Jenkins, D., Molijn, A. C., Struijk, L., van de Sandt, M. M., Doorbar, J., Mols, J., HOOF, C. V., Hardt, K., Struyf, F., et al. (2011) · The Journal of Pathology · doi:10.1002/path.3970 · Cited by 196

Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer

Clifford, G. M., Tully, S., & Franceschi, S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix135 · Cited by 196

Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants

Wentzensen, N., SCHIFFMAN, M. H., Dunn, T., Zuna, R. E., Gold, M. A., Allen, R. A., Zhang, R., Sherman, M. E., Wacholder, S., Walker, J. L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24528 · Cited by 186

Diagnostic performance of human papillomavirus DNA cycle threshold values in the detection of high‐grade cervical intraepithelial neoplasia

Watcharasin, P., Sirimusika, N., Atjimakul, T., & Rattanaburi, A. (2026) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70785

HPV vaccines in China: A narrative review

Zhao, L., Mao, W., & Lu, J. (2026) · One Health Bulletin · doi:10.4103/ohbl.ohbl_78_25

Development of HPV 35 serology assays for assessment of immune responses to HPV 35 after infection and vaccination

Kim, K., Porras, C., Kreimer, A. R., Hempel, H., Kemp, T. J., Lowy, D. R., & Pinto, L. A. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2610897

Public Health Impact and Cost-Effectiveness of Routine and Catch-Up Human Papillomavirus Vaccination in Girls and Women in Selected Regions of China: A Model-Based Study

Fu, X., Zhang, Q., Wagner, A. L., Yao, Y., Xia, Y., Wang, F., & Lu, Y. (2026) · PharmacoEconomics · doi:10.1007/s40273-025-01584-y

Analyzing factors associated with completion of guideline-adherent cervical cancer screening in a county safety-net clinic

Crumbley, C., Khoury, S., Mendonca, A., Juneja, S., Mendonca, C. E., Hirth, J. M., & Rode, R. (2025) · Texas Family Medicine Research Journal · doi:10.65738/001c.154048

Impact of an expanded male catch-up HPV vaccination program on the clinical and economic burden of HPV-associated diseases in Denmark: a modeling study

Honoré, E. T., Fevre, T. L., Pavelyev, A., Sabale, U., Grønhøj, C., & Daniels, V. (2026) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2026.2626567

Changing dynamics of HR-HPV infection and associated cervical precancer in the population-based WOLVES cohort study 15 years after vaccinationPreprint

Denecke, A., Stalp, J. L., Hachenberg, J., Ramachandran, D., Sibbertsen, P., Less, V., & Hillemanns, P. (2026) · Research Square · doi:10.21203/rs.3.rs-8713719/v1

Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis for the Implementation of Public Health Policies for Human Papillomavirus (HPV)-based cervical cancer screening in Brazil

Pagliusi, S. R., Gaspar, P. C., & Miranda, A. E. (2026) · Research Society and Development · doi:10.33448/rsd-v15i2.50636

Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus Genotypes

Dillner, J. (2026) · Current topics in microbiology and immunology · doi:10.1007/978-3-032-17775-9_4

HPV Type Replacement After HPV Vaccination

Anderson, E. M., Saah, A. J., & Tota, J. E. (2026) · Current topics in microbiology and immunology · doi:10.1007/978-3-032-17775-9_6

The projected cost-effectiveness and budget impact of alternative HPV vaccines in Senegal: A modeling study

Laraj, O., Diarra, M., Talla, C., Diop, R., Badiane, O., Pellé, K. G., Kebir, A., Miled, S. B., & Loucoubar, C. (2026) · Vaccine X · doi:10.1016/j.jvacx.2026.100792

Structural and biochemical characterization of neutralizing antibodies targeting human papillomavirus type 45

Jiang, Y., Wang, Z., Xu, Q., Zhang, S., Su, J., Sun, H., Zhang, C., Zhou, L., Li, T., Kong, Z., et al. (2026) · Structure · doi:10.1016/j.str.2026.01.012

Concordance and acceptability of a novel human papillomavirus self-collection tool for cervical cancer screening in economically developed regions: a prospective cohort study in Shanghai, China

Xu, B., Liu, J., Li, H., Zhang, T., & Li, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1760186

Autophagy-Modulated Sonodynamic Therapy Triggers Mitochondrial Catastrophe for Potent Immunogenic Tumor Eradication

Li, M., Song, H., Zhu, Y., Zhang, W., & Jiang, T. (2026) · Biomaterials Research · doi:10.34133/bmr.0348

Distribution and Genotype Diversity of High‐Risk and Low‐Risk Human Papillomavirus in Women Attending Diverse Healthcare Facilities in Sulaymaniyah, Iraq

Mohammed, L. A. O., & Jalal, P. J. (2026) · International Journal of Microbiology · doi:10.1155/ijm/2374286

Association Between Female Genital Schistosomiasis and High-Risk Human Papillomavirus Among Women of Reproductive Age in Zambia: The Schista Study

Lamberti, O., Ndubani, R., Fitzpatrick, J. L., Webb, E., Kasese, N., Nyondo, B., Kosloff, B. R., Cheeba, M. M., Mayaud, P., Lemin, M. E., et al. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag153

A microneedle-assisted CuNWs–MXene heterostructure enables visualized sub-femtomolar detection of cervical cancer miRNA

Chen, A., Jin, J., Luo, J., & Wang, J. (2026) · Journal of Materials Chemistry C · doi:10.1039/d6tc00582a

Need for gender-neutral human papillomavirus vaccination: Lessons from a retrospective epidemiologic investigation of human papillomavirus infections among outpatients presenting to a tertiary dermatology hospital in Central China from 2017 to 2024

Zhou, X., Mo, H., Zhou, Z., Xu, Y., Li, C., & Tao, X. (2026) · IJID Regions · doi:10.1016/j.ijregi.2026.100884

Extended HPV typing as an efficient alternative within HPV ‐based screening programs

Meneses‐León, J., Rivera‐Paredez, B., Hernández-Salazar, S., Torres‐Ibarra, L., Carnalla, M., León-Maldonado, L. S., Hernández‐López, R., Cadena-Fiscal, J. D., Moscicki, A., Quiterio-Trenado, M., et al. (2026) · International Journal of Cancer · doi:10.1002/ijc.70428

Prevalence, lineages and sublineages of human papillomavirus type 16 in background, precancerous diseases and cervical cancer in the North West of Russia

Lyalina, L. V., Kholopov, D. V., Вязовая, А. А., Pleskacheva, A. R., Gladkikh, A. S., Kasatkin, E. V., Zolotarev, A. Y., & Topuzov, E. E. (2026) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-pla-18066

Analytical performance and clinical usability of a low-cost vaginal swab for sensitive detection of high-risk human papillomavirusPreprint

Omballa, V., Luchetta, J., Amaru, R., Joshi, V., Wicker, J., Bennett, W., Solis, L., Mastaglio, B., Cohen, N., & Turnbull, L. B. (2026) · doi:10.12688/verixiv.3093.1

Combination of Vaccine With IL‐12‐Armed Oncolytic Virus SKV‐012 Synergistically Potentiates Immune Responses in HPV‐Associated Malignancies

Yang, N., Xu, L., Zheng, M., Lu, H., Chen, Y., Zhu, Z., Zeng, W., Wang, Z., Li, H., Li, J., et al. (2026) · MedComm · doi:10.1002/mco2.70737

From evidence to action: the IARC’s role in strengthening cancer prevention and early detection

Chandran, A., Togawa, K., Mosquera, I., Selmouni, F., Dimitrova, N., Lucas, E., Muwonge, R., Robbins, H. A., Johansson, M., Park, J. Y., et al. (2026) · JNCI Monographs · doi:10.1093/jncimonographs/lgag001

The role of the health belief model and HPV self-testing in cervical cancer screening participation in the Czech Republic

Janoušková, K., Frei, J., Mainz, D., Papežová, K., Melichová, J., Plančíková, D., Sivčo, P., & Majdán, M. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04467-2 · Cited by 1

Nationwide epidemiology of HPV E6/E7 mRNA in China: genotype distribution in 11,118 women

Xu, S., Li, Y., Yi, X., Yan, Z., Zeng, T., Ning, M. E. N. G., & Sun, J. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1797051

Development of a 12-Valent HPV L1 Virus-like Particle Vaccine Using an Enhanced Baculovirus Expression System

Kim, J.-D., Kim, E.-H., Lee, J. H., Kim, S. M., Oh, J.-M., Cho, Y., Kim, H., Gwak, W., Woo, S.-D., Han, B.-K., et al. (2026) · Vaccines · doi:10.3390/vaccines14050398

Análisis del Manejo de Pacientes con Resultado Alterado en la Autoprueba de VPH: Revisión Sistemática de la Literatura

Cora, J. P. A., & Cruz, F. J. (2026) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2026v72n2.5456es

Analysis of the Management of Patients with Altered Results in the HPV Self-test: Systematic Review of the Literature

Cora, J. P. A., & Cruz, F. J. (2026) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2026v72n2.5456en

Persistent human papillomavirus following mild cytology at screening: implications for age-stratified follow-up and triage

Numminen, E., Leino, A., Kares, S., Kotaniemi‐Talonen, L., Kholová, I., & Louvanto, K. (2026) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000001020

One-tube, protospacer adjacent motif-free and AI-enhanced CRISPR/Cas12a platform for ultra-sensitive detection of human papillomavirus 16 double-stranded DNA

Zou, X., Gu, T., Li, X., Xia, X., Yang, M., Huo, D., & Hou, C. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.152525

Multivalency influences virus dynamics at the glycocalyx: A study of glycosaminoglycan binding in HPV16 entry

Conca, D. V., Bano, F., Abidine, Y., Soria-Martínez, L., Seier, K., Svirelis, J., Dahlin, A., Schelhaas, M., & Bally, M. (2026) · Biophysical Journal · doi:10.1016/j.bpj.2026.05.014

Prevalence and persistence of high-risk HPV genotypes in unvaccinated asymptomatic women: a six-year study in Peru

Laberiano-Fernández, C., del Valle-Mendoza, J., Aguilar-Luis, M. Á., Arias‐Stella, J., Champin, D., de Domínguez, G. R., Perona-Fajardo, F., Imán-Izquierdo, F. J., del Valle, L. J., & Silva-Caso, W. G. (2026) · BMC Research Notes · doi:10.1186/s13104-026-07865-9

Analytical performance and clinical usability of a low-cost vaginal swab for sensitive detection of high-risk human papillomavirusPreprint

Omballa, V., Luchetta, J., Amaru, R., Joshi, V., Wicker, J., Bennett, W., Solis, L., Mastaglio, B., Cohen, N., & Turnbull, L. B. (2026) · doi:10.12688/verixiv.3093.2

High Burden of High-Risk Human Papillomavirus Infections Among Women Living With HIV in Meru, Kenya

Nyamari, C. K., Gachogo, R. W., Nyamache, A. K., & Onyambu, F. (2026) · Cureus · doi:10.7759/cureus.109328

Extended Genotyping as Triage of HPV Positive Screened Women in Low‐and‐Middle Income Countries

der Merwe, F. H. V., Dreyer, G., Visser, C., Dreyer, G. J., Richter, K. L., Snyman, L. C., Adams, R., & Botha, M. H. (2026) · Journal of Medical Virology · doi:10.1002/jmv.70981

Human Papillomavirus Test Agreement Between Self-Collected Vaginal and Clinician-Collected Cervical Specimens

Cyriac, J., Theel, E. S., Long, M. E., Maxson, J. A., Cole, K. C., Lin, I., McCann, J., Gallagher, E. M., Meunier, M. R., Jacobson, R. M., et al. (2026) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000962

Urban–rural disparities in HPV prevalence and genotype distribution: a large-scale cervical cancer screening study in Xi’an, China

Wu, J., Yi, J., Fang, L., Lei, S., Yang, H., Ma, M., Hao, Y., Kim, H., Shin, H., & Choi, W. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13647-2

HPV genotype-specific p16/Ki67 expression with machine learning-assisted assessment in cervical neoplasia

Oguzhanoglu, M. K., Uzuner, E. G., Oguzhanoglu, K., Cetin, A., Karacabey, S., & Asgarova, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1819567

Distribution of human papilloma virus genotypes in cancerous lesions of cervix: Insights from a hospital-based study in Bangladesh

Begum, S. A., Mahmud, T., Amatullah, M., & Nessa, A. (2026) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_1037_25

Screening for anal high-grade squamous intraepithelial lesions with flexible endoscopy in high-risk individuals

Borch-Johnsen, P., Filén, F., Darai‐Ramqvist, E., Dobra, K., Storgärd, E., Ekström, A. M., Rosenblad, A., Sällström, S., Nygren, J., & Schmidt, P. T. (2026) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2026.2678599

High-risk oncogenic HPV genotypes in vulnerable women from the Amazon: a cross-sectional retrospective study

Cordovil, D. C., Reis, L. D. D. S., Ferreira, L. S. S., Sequeira, C. G., Bezerra, T. D. M., Oliveira, E. H. C., Laurentino, R. V., Macchado, L. F. A., dos Santos, L. M., Ventura, A. M. R. D. S., et al. (2026) · Virology Journal · doi:10.1186/s12985-026-03220-3

Resource‐Adapted Triage Strategies for Women Testing HPV Positive With Self‐Collected Vaginal Samples in Cameroon

Murtas, M., Vassilakos, P., Wisniak, A., Hu, K., Arbyn, M., Happi, G. W. T., Abatsong, E., Nsangou, F. M. N., Tille, J., Saïji, E., et al. (2026) · International Journal of Cancer · doi:10.1002/ijc.70573

Mismatch Between Vaccine Targets and Endemic HPV Genotypes in Sarawak, East Malaysia: Implications for Cervical Cancer Prevention

Jerip, A. R., Noni, V., Senian, A. A., Bong, A. C. S., Adam, J., Sidik, N. T., Idi, A., Kyaing, Y. Y., Siri‐ee, D., Ibrahim, S. F., et al. (2026) · Journal of Medical Virology · doi:10.1002/jmv.71010

Genetic Variation of HPV53 and the Identification of T-Cell Epitopes

Wang, L., Jiao, S., Lan, S., ZHANG, Y., Yu, J., He, J., Zhang, H., & Feng, M. (2026) · Microorganisms · doi:10.3390/microorganisms14071395

Monitoring the safety of the adjuvanted human papillomavirus vaccine HPV-16/18-AS04 in association with pregnancy and potential immune-related diseases in China: A retrospective observational cohort study

Yang, J., Navarro-Torné, A., Liu, Z., Guo, J., Deng, S., Meng, R., Yang, Y., Evans, R., Poddar, A., Yun, H., et al. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2681265

Innovations in HPV vaccination and their role in global cervical cancer control: a review

Chuwa, A. H. (2026) · Therapeutic Advances in Vaccines and Immunotherapy · doi:10.1177/25151355261449446

The role of colposcopy in the clinical diagnosis and management of cytology-negative, non-16/18 high-risk HPV positive patients

Çaltek, N. Ç., Yassa, M., Şahin, G., Kayan, B. Ö., Yaman, İ., & Yüksel, İ. T. (2026) · Journal of Medicine and Palliative Care · doi:10.47582/jompac.1908071

Exploring Human Papillomavirus 16 Long Control Region Variants in Paraguayan Women: Comparing Variant Diversity to Transcriptional Activity and Cervical Lesion Severity

Mongelós, P., Pereira, I. M. M., Díaz-Ferreira, N. J., Talpe‐Nunes, V., Valenzuela, A., Amarilla, M. A. M., Miranda-Echagüe, M. R., Aguirre, L. E. B., Kasamatsu, E., Páez, M., et al. (2026) · International Journal of Microbiology · doi:10.1155/ijm/2292032

Artificial Intelligence for Cervical Human Papillomavirus Infection and Lesion Screening: A Cross-Sectional Analysis of Its Application Potential and Patient Satisfaction

Zheng, P., Yang, Y., Li, S., Zhang, J., Gu, F., & Li, H. (2026) · Gynecologic and Obstetric Investigation · doi:10.1159/000553436

Risk Factors for High-Risk Human Papillomavirus Infections Among Female Students Identified Through Self-Sampling in Benin City, Edo State

Omoruyi, E. C., Fowotade, A., Fowotade, A. A., Omosigho, P. O., & Agbonlahor, D. E. (2026) · Venereology · doi:10.3390/venereology5030017

Data-augmented multistate modeling for chronic disease processes using cross-sectional studies: application to HPV and cervical precancer

Mao, F., Campos, N. G., & Cheung, L. C. (2026) · Biostatistics · doi:10.1093/biostatistics/kxag022

The prevalence of human papillomavirus infection among women in primary health care, Santiago, Chile (2015–2024)

Bruneau, N., Balanda, M., Martín, H. S., Muñoz, T., Roldán, F., Hernández, D., Fernández, J., Soto, M., Santis-Alay, N. T., Ortúzar, I., et al. (2026) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2026.100776

Natural Versus Vaccine-Induced Immunity Against HPV: A Comparative Review of Antibody Response and Cancer Prevention

Ghilencea, B., Moroianu, B. I., Năstac, A., Bostan, I.-S., Panaitescu, A. M., Mehedințu, C., & Gică, N. (2026) · Antibodies · doi:10.3390/antib15040061

Longitudinal analysis of high-risk HPV infections reveals within-host viral genome changes over time

Mishra, S. K., Yeager, M., Nelson, C. W., Zhu, B., Burdett, L. A., Burk, R. D., Dean, M. C., Herrero, R., SCHIFFMAN, M. H., Rodriguez, A. C., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014362

Preanalytical stage: comparison of the efficiency of using a cytobrush and a urogenital probe type A in collecting samples for PCR-diagnostics of HPV

Khoperskaya, O. V., Enkova, E. V., Fedotova, E. I., Rozenberg, S. Z., Levenets, S. A., & Malyutkina, T. N. (2026) · Consilium Medicum · doi:10.26442/20751753.2026.7.203617

Agreement and Diagnostic Performance of Urinary HPV Testing Versus Clinician-Collected Cervico-Vaginal Sampling: A Prospective Cross-Sectional Study in a Romanian Cohort

Nati, I. D., Oancea, M. D., Mihu, C. M., Mihu, D., Ciortea, R., Iuhas, C. I., Bucuri, C. E., roman, M. P., Ormindean, C. M., Suciu, V.-E., et al. (2026) · Medical Sciences · doi:10.3390/medsci14040423

Impact of HPV vaccination on cervical precancer and invasive cervical cancer twelve years after vaccine introduction in the Brazilian Public Health System

Carneiro, F. P., Chen, S. D. S. R., Oliveira, Í. D. A., Amancioa, F. F. C., Sousa, A. L. D. S., Carneiro, M. D. V., Resende, C. N., & Motoyama, A. B. (2026) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2026.103326

Targeting the HPV E6–p53 degradation axis via computational and in vitro identification of a repurposed small-molecule candidate

Harishkumar, S. D., Pasha, S., Edwin, R., Madashetty, S., Shreevatsa, B., Kollur, S. P., Shivamallu, C., & Dharmashekar, C. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1913599

Human Papillomavirus Infection and Cervical Cancer Risk Modelling Among Women in Niamey, Niger Republic

Larwanou, H. M., Lagaré, A., Hounkanrin, W., Issa, M., Hassane, F., Eric, A. O., & Zoubeirou, A. M. (2026) · European Scientific Journal ESJ · doi:10.19044/esj.2026.v22n21p35

The microbiota-host metabolic axis in cervical cancer: from homeostatic disruption to mechanisms of therapy resistance

He, Y., Zhao, Y., Ju, S., Zhou, P., Si, J., Pan, Y., & Jiang, Y. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1890330

Extended HPV Genotyping for Risk Stratification in Cervical Screening: A Population-based Study

Kfir, S., Barkan, Y., Siegler, E., Razi, T., & Arbel, R. (2026) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000975

Family Physicians’ Knowledge Levels and Awareness Regarding HPV Infection and HPV Vaccines

Yurdakul, F. E., Acat, Ö., & Uzun, L. (2026) · Healthcare · doi:10.3390/healthcare14162457

Clinical Impact of HPV Self-Sampling and Molecular Biomarkers on Cervical Cancer Screening and Triage: “The Times They Are A-Changin’”—A Comprehensive Review and Future Perspectives

Liverani, C. A., Boero, V., Monti, E., Caia, C., Natalini, L., Vercellini, P., Vignali, M., & Ciavattini, A. (2026) · Cancers · doi:10.3390/cancers18162576

Human papillomavirus detection in liquid-based cytology and cervical histology samples among women living with human immunodeficiency virus in Zambia

Taghavi, K., Moono, M., Villalobos, N. V. F., Andoh, J., Glass, A., Basu, P. S., Madliwa, T., Mwanahamuntu, M., Manasyan, A., & Rohner, E. (2026) · IJID Regions · doi:10.1016/j.ijregi.2026.100973

Hispidulin and nepetin as promising phytochemical inhibitors of HPV E6: Insights from in silico analysis

Debbarma, M., Sarkar, K., Kunnumakkara, A. B., & Sil, S. K. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100546

Clinical Validation of the Sansure Human Papillomavirus DNA Diagnostic Kit for Use in Primary Cervical Cancer Screening

Dhillon, S. K., Latsuzbaia, A., Broeck, D. V., Prétet, J., Tkachenka, Y., Lepiller, Q., Baraquin, A., Jacquot, K., Pereira, A. R., Redzic, N., et al. (2026) · Journal of Medical Virology · doi:10.1002/jmv.71106

Improving cervical screening risk stratification through extended human papillomavirus genotyping and age-specific data

Leino, A., Numminen, E., Veronika, F., Paloniemi, M., Seiskari, T., Kholová, I., Kares, S., & Louvanto, K. (2026) · European Journal of Public Health · doi:10.1093/eurpub/ckag139

The effect of HPV vaccination on precancerous lesions and invasive cervical cancer in a low-vaccination-coverage setting in Germany: a retrospective cohort analysis

Awuah, G. B., Fett, S., Schauberger, G., Osmani, V., Tauscher, M., Röbl-Mathieu, M., Kiechle, M. B., & Klug, S. J. (2026) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2026.101830

Proteome-wide curation of experimentally validated HPV T-cell epitopes identifies key gaps in our understanding of cellular immunity to HPV and informs vaccine design

Putra, S. P., Cankat, S., & Swadling, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1917170

HPV Genotype Distribution in Cervical Cancer and High‐Grade Lesions in Norway, and Early Vaccine Impact

Bekkevold, T., Laake, I., Feiring, B., Søreng, K., Presthus, G. K., Alfsen, G. C., Christiansen, I. K., Hansen, M., Kristiansen, H., Olsen, E., et al. (2026) · International Journal of Cancer · doi:10.1002/ijc.70712

Chrysin treatment is associated with altered microrna expression and reduced levels of HPV16 E6 protein in caski cervical cancer cells

Fashkhami, M. G., Habibollahi, H., & Shafighi, S. T. (2026) · Medical Oncology · doi:10.1007/s12032-026-03381-9

Predictive Contribution of p16 Beyond HPV Genotype in the Histopathologic Detection of CIN2+ Lesions: A Real-World Cervical Biopsy Cohort Study

ÖZEN, E. G., Özen, S., Tanyeri, D., Tanyeri, U., & Sancı, M. (2026) · Diagnostics · doi:10.3390/diagnostics16172784

Association of HLA-G alleles with type-specific HPV seropositivity and seropersistence in unvaccinated women: A prospective cohort study

Anttonen, K., Kalliomaa, N., Roger, M., Faucher, M.-C., Waterboer, T., Syrjänen, S., & Louvanto, K. (2026) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2026.106017

Evidence for type replacement as a consequence of vaccination and implications for cervical screening

Gray, P. G., & Louvanto, K. (2026) · JNCI Monographs · doi:10.1093/jncimonographs/lgag011

International Papillomavirus Society statement on reputed treatments for human papillomavirus infection and human papillomavirus-related diseases: evidence, risks, and standards for clinical evaluation

Mühr, L. S. A., Mungo, C., Chatzistamatiou, Κ., Leung, S. O. A., Garland, S. M., Mühr, L. S. A., Adsul, P., Bhatla, N., Bosch, F. X., Brotherton, J., et al. (2026) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2026.104950

A droplet digital PCR assay targeting 16 human papillomavirus genotypes

Murray, G. L., Balgovind, P., Tabrizi, S. N., Morris, B., French, P. W., Yilmaz, E., Mühr, L. S. A., & Garland, S. M. (2026) · Access Microbiology · doi:10.1099/acmi.0.001166.v3

Heterogeneity in Risk of Recurrent CIN2+ Among Women With Genotype-Specific HPV Detected After Excision: A Cohort Study

Lomozová, D., Dvořák, V., Malinová, J., Hradecký, J., Trnková, M., Rob, L., Janovská, N., Dlouhý, P., Rosina, J., Lesná, I. K., et al. (2026) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000970

Stellenwert serologischer (Schnell‑)Teste zur Früherkennung HPV-bedingter Karzinome

Wieland, U., & Waterboer, T. (2026) · Die Dermatologie · doi:10.1007/s00105-026-05780-5

Geographic and temporal variations in cancer incidence attributable to human papillomavirus infection in China: a population-based study

Liu, J., Hu, J., Zhu, Q., Chen, R., Ye, J., Zheng, Y., Wei, F., Luo, G., & Zhang, Y. (2026) · BMC Public Health · doi:10.1186/s12889-026-29368-9

Determinants and Strategies for Implementation of the HOPE Self-Sampling Cervical Screening Intervention for Women Living with HIV in Ghana: A Context Assessment and Implementation Mapping StudyPreprint

Sam-Agudu, N. A., Coker, K. A.-A. R., Frueh, E., Cudjoe, O., Ken‐Amoah, S., Enyan, N. I. E., Nuer-Allornuvor, G. F., Abrefah, E., Dankyi, A. B., Akakpo, P. K., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10695564/v1

Prevalence and risk factors of human papillomavirus infection and cervical cytological lesions among women in Shanxi, China: a cross-sectional study

Ge, S., Gao, H., Wang, J., Guo, S., Chang, Y., Qi, Y., Han, J., Jia, Y., Dong, J., & Wei, F. (2026) · Virology Journal · doi:10.1186/s12985-026-03300-4

Advances in HPV protein-based detection technologies for early diagnosis of cervical cancer

Xu, Q., Yu, W., Wu, X., Lou, X., & Xia, F. (2026) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2026.120582

Development of a multiplex quantitative real-time PCR (qPCR) assay for simultaneous detection of Schistosoma haematobium and high-risk human papillomaviruses

Donkoh, E. T., Williams, I., Akologo, R. N., Asiedu, A. A., -Atta, R. J. O., Boadu, I. W. O., Ryabinina, O., Forson, A. O., Boampong, K., Jain, N., et al. (2026) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0014694

Impact of menopausal status on human papillomavirus detection and cervical neoplasia in middle-aged Senegalese women

Spencer, E. R., Winer, R. L., Ba, S., Sy, M. P., Lin, J. W., Feng, Q., Gottlieb, G. S., Sow, P. S., Kiviat, N. B., & Hawes, S. E. (2026) · PLoS ONE · doi:10.1371/journal.pone.0358080

Impfprävention HPV-assoziierter Erkrankungen

Wieland, U., & Kreuter, A. (2026) · Die Dermatologie · doi:10.1007/s00105-026-05786-z

Impact of HPV vaccination in Spain: Reductions in vaccine-type genotypes, cytological abnormalities, and the influence of epidemiological factorsPreprint

Señán, A. I. G., Lamo, E. A., Expósito, A. D., Martin, M. A., Miranda, J. W. C., Pena, D. D. V., Trivino, M. R. R., Cousido, S. P., Eguizábal, B. D., Antolín, M. C., et al. (2026) · medRxiv · doi:10.64898/2026.09.10.26362440

Prospects of artificial intelligence in multimodal integration of methylation and imaging features for precision cervical cancer screening

Li, C., 刘列, Yang, Y., & Zhan, L. (2026) · Current Radiopharmaceuticals · doi:10.1016/j.craph.2026.100094

From HPV genotypes to cervical lesion burden: public health-relevant heterogeneity across 1.29 million screening records in Guangdong, China

Zhao, Q., Yang, C., Bu, Q., Sun, X., Hu, G., He, L., Wei, Z., 王功业, Luo, X., Gu, J., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1897790

Primary Pap Smear Cytological Diagnosis of ASC-US: HR-HPV Genotyping and Follow-Up of HPV-Positive Patients

Pisani, T., Cenci, M., & Capoluongo, E. (2026) · Cancers · doi:10.3390/cancers18183022

Regional Diversity of Human Papillomavirus Genotypes in Southeastern Brazil: Implications for Cervical Cancer Screening

Dalvi, D. D., Cruz, A. M. G., Rocha, P. S. D. O., Segantine, E. R. D. P., Grillo, D., Goulart, J. P., Miranda, A. E., & Ribeiro‐Rodrigues, R. (2026) · Journal of Medical Virology · doi:10.1002/jmv.71140

Cervicovaginal Virome Restructuring Associated with HPV Status, Bacterial Dysbiosis, and Cervical Cytological Abnormalities

Kushugulova, A. R., Kamzayeva, N., Kozhakhmetov, S., Vinogradova, E. B., Jarmukhanov, Z., Mukhanbetzhanov, N., Kovenskiy, A., Kossumov, A., Rakhmankulova, A. M., & Ukybassova, T. (2026) · Viruses · doi:10.3390/v18091036

Wastewater-Based Surveillance of Human Papillomavirus Genotype Diversity

Michon, P., Cluzel, N., Maday, Y., Prétet, J., Guérin, S., Lecat, R., Thiebault, T., & Maréchal, V. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.35063

Menstrual, reproductive, and contraceptive factors associated with cervical cancer in women aged ≤35 years: an individually matched case–control study

Liu, L., Zhang, Y., He, L., & Zhou, L. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1931698

Prevalence and genotype distribution of human papillomavirus infection among women undergoing HPV testing at a hospital in Zhangzhou, China: a retrospective study

Xu, W., Guo, Y., Chen, W., Wang, G., Wu, Q., & Zeng, Y. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1907680

Human Papillomavirus Genotype Distribution among Adult Women in the Rabat Region (Morocco): A Retrospective and Analytical Study with Implications for HPV Vaccination Strategies

Tagajdid, M. R., Azelmat, S., Goura, H., Znady, M. R., Mansouri, D., Abi, R., Elannaz, H., Elkochri, S., Laraqui, A., Bouaiti, L., et al. (2026) · Intervirology · doi:10.1159/int/adgag002

Genotype-specific agreement and accuracy of human papillomavirus DNA detection using AnyplexTM II HPV28 and XpertTM HPV among women with HIV in Lusaka, Zambia: a diagnostic accuracy analysis

Villalobos, N. V. F., Pohl, M., Andoh, J., Glass, A., Basu, P. S., Madliwa, T., Mwanahamuntu, M., Rohner, E., Low, N., Manasyan, A., et al. (2026) · IJID Regions · doi:10.1016/j.ijregi.2026.101027

Spotlights on cervical cancer: progression, diagnosis and clinical manifestations, epidemiology, treatment approaches, role of artificial intelligence and future directions

Tawfeek, H. M., Abdellatif, A. A., & Barakat, H. (2026) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2026.2741083

Impact of HPV vaccination on high-risk HPV prevalence in 25-29-year-old women attending cervical screening in England 2016-2025Preprint

Slater, L., Panwar, K., Checchi, M., Viviani, L., Sargent, A., Frew, V., Mackenzie, B., Beddows, S. A., & Soldan, K. (2026) · medRxiv · doi:10.64898/2026.09.28.26364150

Human Papillomavirus Prevalence and Genotype Distribution in Unvaccinated Women: A Gynaecology and Obstetrics Hospital-Based Retrospective Study in México

Flores‐Medina, S., Sam-Soto, S., Plazola-Camacho, N. G., Figueroa-Damián, R., Reyna-Rosas, E., Arteaga-Gómez, C., & Rocha‐Zavaleta, L. (2026) · Microorganisms · doi:10.3390/microorganisms14102210

Intratumoral microbiota: bidirectional modulation of tumor radiosensitivity

Zhu, F., Han, S., Jia, W., Cao, Y., & Zhu, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1945760

Causal Attribution of Human Papillomavirus Types to Invasive Cervical Cancer Worldwide: A Systematic Analysis of the Global LiteraturePreprint

Wei, F., Georges, D., Man, I., Baussano, I., & Clifford, G. M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4692586 · Cited by 4

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728

HPV genotypes: implications for worldwide cervical cancer screening and vaccination

de Sanjosé, S. (2010)

Identification of HPV genotypes causing cervical precancer using tissue‐based genotyping

Venetianer, R., Clarke, M. A., van der Marel, J., Tota, J. E., SCHIFFMAN, M. H., Dunn, S. T., Walker, J. L., Zuna, R. E., Quint, W. G. V., & Wentzensen, N. (2020) · International Journal of Cancer · doi:10.1002/ijc.32919 · Cited by 23

Ranking the attribution of high-risk genotypes among women with cervical precancers and cancers: a cross-sectional study in Ningbo, China

Chen, S., Hu, S., Yin, J., Yu, W., Zhang, X., Deng, X., Ding, H., Zhang, J., Song, Y. Y., Wang, Q., et al. (2024) · Infectious Agents and Cancer · doi:10.1186/s13027-024-00598-z · Cited by 1